AnaptysBio
ANAB
ANAB
134 hedge funds and large institutions have $2.53B invested in AnaptysBio in 2018 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 43 increasing their positions, 43 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
+18
Holders Change %
+15.52%
% of All Funds
3.08%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
37
Increased
43
Reduced
43
Closed
18
Calls
$40.7M
Puts
$54.1M
Net Calls
-$13.4M
Net Calls Change
-$19.7M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$52.3M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$47.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35.8M |
| 4 |
State Street
Boston,
Massachusetts
|
+$32.5M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$31.6M |
Top Sellers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$56.5M |
| 2 |
PA
Perceptive Advisors
New York
|
-$54M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$37M |
| 4 |
Morgan Stanley
New York
|
-$29.7M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$21.7M |
